FEDERAL TRADE COMMISSION v. BRISTOL-MEYERS SQUIBB COMPANY | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for FEDERAL TRADE COMMISSION v. BRISTOL-MEYERS SQUIBB COMPANY

Sort by

Viewing results 1‒25 of 30

The Week Ahead
Nato boss seeks to strengthen Asian alliances
...Key economic and company reports Here is a more complete list of what to expect in terms of company reports and economic data this week....
January 29, 2023
Special ReportRegulated Markets
Pharma dealmaking hit by greater scrutiny of prices and competition
...In March last year, the Federal Trade Commission (FTC) joined with its EU, UK and Canadian counterparts to announce they would rethink their approach to M&A by “Big Pharma”, noting the high volume of recent...
February 28, 2022
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
Markets InsightAndrew Baum
Pharma investors should brace for pricing and antitrust action
...Even under the Trump administration, there were signs that the US Federal Trade Commission was taking a more aggressive antitrust approach....
June 7, 2021
Energy sector
Energy grids target upgrades for zero carbon transition
...A recent ruling by the US Federal Energy Regulatory Commission (Ferc) will even allow the owners of household solar systems, electric vehicle batteries and other small energy resources to sell their excess...
April 26, 2021
Covid-19 vaccines
Merkel rejects US move to waive patents on vaccines
...The chief executive of Bristol-Myers Squibb described the US government’s support for waiver as “very concerning” during an interview at the FT US Pharma and Biotech Summit on Thursday....
May 6, 2021
AbbVie Inc
US regulator clears AbbVie’s $63bn deal for Allergan
...The Federal Trade Commission announced on Tuesday it had voted 3-2 to approve the acquisition after the companies agreed to sell some of Allergan’s assets to Nestlé and AstraZeneca....
May 6, 2020
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Bristol-Myers Squibb Co
Bristol-Myers Squibb trims earnings guidance on Celgene deal
...Any deal would need to be agreed with the Federal Trade Commission, which would issue a consent decree for the Celgene acquisition, the company said....
July 25, 2019
Celgene Corp
Amgen to buy Celgene’s Otezla in $13.4bn deal
...He also questioned whether the Federal Trade Commission would approve the deal, given Amgen already has a significant presence in the same disease area....
August 26, 2019
FirstFT
FirstFT: Today’s top stories
...According to SEC filings, Elon Musk’s company is the $60bn hedge fund’s second largest holding, behind Bristol-Myers Squibb....
February 18, 2020
News in-depthWearable technology
Google runs into data fears over $2.1bn Fitbit deal
...Privacy and antitrust advocates have called on the Federal Trade Commission to block the purchase, arguing that health data are “critical” to the future of the digital marketplace....
November 22, 2019
Due Diligence
M&A optimists get a dose of reality Premium content
...The best example is Bristol-Myers Squibb’s $90bn (agreed) deal to acquire rival drugmaker Celgene....
March 15, 2019
World
The FT Diary looks at the main events making the news this week
...its closest rival in this field, Bristol-Myers Squibb....
January 29, 2017
Law
Corporate: Sweetening the pill
...The pharmaceuticals industry lobbied hard, and the Federal Trade Commission, 32 state attorneys-general and both houses of Congress held hearings....
November 29, 2012
LexMergers & Acquisitions
Bristol-Myers Squibb
...Of course, the deal was not in the bag, since it was still awaiting the green light from the Federal Trade Commission and state authorities....
July 27, 2006
US & Canadian companies
Bristol-Myers to weigh options on Plavix
...The settlement provided Apotex with at least $40m – a provision that US regulators at the Federal Trade Commission questioned....
September 11, 2006
FT Live
FTWeekend Festival: U.S. edition
Where the Financial Times weekend paper comes to life
Saturday, 4 MayThe REACH, at the Kennedy Center for the Performing Arts, F Street Northwest, Washington, DC, USA
US & Canadian companies
US judge blocks generic Plavix sale
...But such so-called “reverse settlements” that provide compensation to delay cheaper generic medicines have come under scrutiny by US regulators at the Federal Trade Commission....
August 31, 2006
US financial regulation
Plavix patent dispute escalates
...Apotex said it alerted the Federal Trade Commission to efforts by a senior Bristol executive, Andrew Bodnar, allegedly to deceive the government about verbal agreements outside settlement provisions....
August 18, 2006
Health sector
Bristol and Sanofi caught off-guard by investigation
...However uncomfortable, Bristol and Sanofi had braced for the uncertainty of a necessary US Federal Trade Commission civil antitrust review for the deal that delays generic competition for Plavix....
July 28, 2006
US & Canadian companies
New evidence sheds light on Plavix case
...Apotex claims that Bristol’s top negotiator attempted to mislead the Federal Trade Commission in an effort to get approval for the settlement by offering separate secret verbal side agreements as part of...
August 21, 2006
US & Canadian companies
Bristol and Sanofi brace for drug ruling
...If regulators reject the deal, which is also being reviewed by federal antitrust regulators at the Federal Trade Commission in Washington, Apotex will be likely to pursue its patent challenge against the...
July 23, 2006
US & Canadian companies
Plavix patent litigation deal rejected
...Bristol and Sanofi filed revised terms last month to the state attorneys general and Federal Trade Commission, who were reviewing the deal....
July 28, 2006
US & Canadian companies
Plavix deal faces US DoJ probe
...Bristol of the US and Sanofi of France – which jointly market Plavix – are negotiating with the Federal Trade Commission and state authorities for approval of their deal with Apotex, a generic drugmaker...
July 28, 2006
US & Canadian companies
Plavix deal under criminal investigation
...Bristol and Sanofi, of the US and France respectively, are negotiating with the Federal Trade Commission (FTC) and some state authorities for approval of their deal with Apotex, a small generic drugmaker...
July 27, 2006
US downturn
Court declines to intervene in pharmaceuticals antitrust case
...It is currently reviewing a settlement that Bristol-Myers Squibb and Sanofi-Aventis reached with a generic company over their blockbuster drug, Plavix....
June 26, 2006
UK companies
Shire settles key patent dispute with Barr
...The Federal Trade Commission has recently increased its scrutiny of the deals between pharmaceutical groups and their generic competitors and branded those in which drug groups offer substantial payments...
August 15, 2006

Previous pagePage 1 of 2Next page